Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | CA12 | O43570 | 2/20 | 0.67 |
| ▸ | CA9 | Q16790 | 2/20 | 0.67 |
| ▸ | CA1 | P00915 | 2/20 | 0.67 |
| ▸ | CA2 | P00918 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL12481388 | 0.98 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM | |
| Hydrochloric Acid SCHEMBL7362553 | 0.98 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM | |
| SCHEMBL7926317 | 0.93 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM | |
| SCHEMBL28717153 | 0.89 | CA12 (0.64) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM | |
| SCHEMBL8851674 | 0.89 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM | |
| SCHEMBL27712513 | 0.88 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM | |
| SCHEMBL51729 | 0.88 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM | |
| SCHEMBL8349568 | 0.87 | ALDH1A1 (0.79) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM | |
| Methane SCHEMBL27933203 | 0.86 | ALDH1A1 (0.73) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM | |
| Benzene SCHEMBL27648656 | 0.86 | ALDH1A1 (0.73) | ALDH1A1SMN1; SMN2LMNAKDM4EPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | GENECODE (EE) | 2026-01-22 | — | — | US | claimed |
| US-12515397-B2 | Three-dimensional printed part | PERIDOT PRINT LLC (US) | 2026-01-06 | — | — | US | claimed |
| US-20240042680-A1 | THREE-DIMENSIONAL PRINTED PART | PERIDOT PRINT LLC | 2024-02-08 | — | — | US | claimed |
| US-11801631-B2 | Three-dimensional printed part | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2023-10-31 | — | — | US | claimed |
| US-20220009161-A1 | THREE-DIMENSIONAL PRINTING | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-01-13 | — | — | US | claimed |
| CN-113527152-A | Biphenylsulfonamide compound and method for preventing and treating crop pests by using same | 西北农林科技大学 | 2021-10-22 | — | — | CN | claimed |
| CN-113227036-A | Ethylenediamine compound and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2021-08-06 | — | — | CN | claimed |
| US-20210197445-A1 | THREE-DIMENSIONAL PRINTED PART | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2021-07-01 | — | — | US | claimed |
| CN-108164503-B | A kind of heteroaromatic and the disubstituted benzenesulfonamides of alkyl side chain and its preparing the application in anti-influenza A virus medicament | 武汉大学 | 2019-09-17 | — | — | CN | claimed |
| CN-108440856-A | Dye-colored body and method for producing same | 谦华科技股份有限公司 | 2018-08-24 | — | — | CN | claimed |
| WO-2005030209-A1 | PYRIDINE DERIVATIVES AND USE THEREOF AS UROTENSIN II ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2005-04-07 | — | — | WO | claimed |
| WO-2005026129-A1 | PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES | GPC BIOTECH AG (DE) | 2005-03-24 | — | — | WO | claimed |
| WO-2005014596-A1 | 7-SUBSTITUTED 3-NITRO-PYRAZOLO `1,5-A! PYRIMIDINES | FERRER INTERNACIONAL, S.A. (ES) | 2005-02-17 | — | — | WO | claimed |
| US-6828375-B2 | Containing a thermoplastic elastomer grafted with maleic anhydride, carbon black powder, sulfonamide based material, and alkanedioic acid | HYUNDAI MOTOR COMPANY (KR) | 2004-12-07 | — | — | US | claimed |
| EP-1165866-B1 | ABRASIVE FILAMENTS OF PLASTICIZED POLYAMIDES | DU PONT (US) | 2004-01-28 | — | — | EP | claimed |
| EP-1283832-A1 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 | BIOVITRUM AB (SE) | 2003-02-19 | — | — | EP | claimed |
| US-20020128373-A1 | Electroconductive polyamide resin composition and molded product for motor component prepared therefrom | HYUNDAI MOTOR COMPANY (KR) | 2002-09-12 | — | — | US | claimed |
| WO-2001090092-A1 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 | BIOVITRUM AB (SE) | 2001-11-29 | — | — | WO | claimed |
| US-5437690-A | Using an n-alkyl aromatic sulfonamide as dye promoter in dyeing aromatic polyamides, polybenzimidazoles, polyimides | SPRINGS INDUSTRIES, INC. (US) | 1995-08-01 | — | — | US | claimed |
| US-4968737-A | Molding compounds comprising a thermoplastically processible aromatic polyamide | HUELS AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | CNR1, CDR2, SMN1; SMN2 | ALDH1A1 1383/4885SMN1; SMN2 3/4885LMNA 1359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.